Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non-Current Assets: 2019-2022

Historic Non-Current Assets for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $83.2 million.

  • ADC Therapeutics' Non-Current Assets fell 2.52% to $91.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $91.3 million, marking a year-over-year decrease of 2.52%. This contributed to the annual value of $83.2 million for FY2022, which is 10.39% down from last year.
  • According to the latest figures from FY2022, ADC Therapeutics' Non-Current Assets is $83.2 million, which was down 10.39% from $92.8 million recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Non-Current Assets ranged from a high of $92.8 million in FY2021 and a low of $15.1 million during FY2019.
  • In the last 2 years, ADC Therapeutics' Non-Current Assets had a median value of $88.0 million in 2021 and averaged $88.0 million.
  • Data for ADC Therapeutics' Non-Current Assets shows a maximum YoY fell of 10.39% (in 2022) over the last 5 years.
  • Over the past 3 years, ADC Therapeutics' Non-Current Assets (Yearly) stood at $15.1 million in 2019, then reached $92.8 million in 2021, then declined by 10.39% to $83.2 million in 2022.